Volume | 0 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Tarsus Pharmaceuticals Inc | TARS | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
34.63 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 12.57 - 40.40 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
- | 0 | $ 34.63 | USD |
Tarsus Pharmaceuticals Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
1.19B | 34.22M | - | 17.45M | -135.89M | -3.97 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Tarsus Pharmaceuticals News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TARS Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 32.57 | 34.63 | 30.225 | 32.49 | 547,287 | 2.06 | 6.32% |
1 Month | 34.76 | 38.46 | 30.225 | 34.31 | 519,847 | -0.13 | -0.37% |
3 Months | 31.00 | 40.40 | 28.42 | 34.12 | 697,855 | 3.63 | 11.71% |
6 Months | 14.93 | 40.40 | 14.87 | 26.98 | 707,840 | 19.70 | 131.95% |
1 Year | 14.68 | 40.40 | 12.57 | 23.51 | 545,063 | 19.95 | 135.90% |
3 Years | 30.85 | 40.40 | 10.8001 | 21.91 | 239,928 | 3.78 | 12.25% |
5 Years | 18.30 | 63.69 | 10.8001 | 22.60 | 213,704 | 16.33 | 89.23% |
Tarsus Pharmaceuticals Description
Tarsus Pharmaceuticals Inc is a late clinical-stage biopharmaceutical company. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's lead candidate TP-03, is a novel drug that targets the Demodex mite nervous system to kill the mites. |